Cancer Treatment in North Carolina: Research to Practice webinars cover the spectrum of anti-cancer therapy, with a focus on recent research developments, both locally and at large, and what’s ready for regular practice. Perspectives from medical oncology, radiation oncology, and surgery will be included.

The webinar series incorporates an understanding of practice dynamics and concerns throughout the state of North Carolina, and the availability of clinical trials and subspecialty expertise to inform care.

Live Webinars          Self-Paced Online Courses
 

Receive FREE Continuing Education Credits
CME • NCPD/CNE • ACPE • ASRT • CTR


Upcoming Live Course

Feature image for Obesity and Cancer Prevention: The Efficacy and Timing of Bariatric Surgery 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Live Webinar
March 27 • 12:00 – 1:00

Obesity and Cancer Prevention: The Efficacy and Timing of Bariatric Surgery
Maggie M. Hodges, MD, MPH
 

 

Feature image for Current Concepts in Spinal Oncology 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Live Webinar
April 24 • 12:00 – 1:00

Current Concepts in Spinal Oncology
Michael Galgano, MD, FAANS

This webinar will focus on differentiating the various types of spinal tumors, ranging from metastases, to primary vertebral column tumors, and intradural spinal cord tumors. We will discus the contributions of co-morbidities and frailty on the management of patients with spinal tumors. We will aim to give the audience a brief exposure to the surgical management of spinal oncology, and what is entailed to execute robust local control.

 

Feature image for Radiation Oncology in North Carolina 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Live Webinar
May 22 • 12:00 – 1:00

Radiation Oncology in North Carolina
Kevin Pearlstein, MD
 

 

Feature image for Surgical Oncology in North Carolina 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Live Webinar
June 26 • 12:00 – 1:00

Surgical Oncology in North Carolina
Kristalyn Gallagher, DO, FACOS, FACS
 

 

Feature image for Multiply Myeloma in North Carolina 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Live Webinar
August 28 • 12:00 – 1:00

Multiple Myeloma in North Carolina
Samuel M Rubinstein, MD
 

 

Feature image for Genitourinary Cancer Management in North Carolina 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Live Webinar
September 25 • 12:00 – 1:00

Genitourinary Cancer Management in North Carolina
Matthew I. Milowsky, MD, FASCO
 

 

Feature image for Lymphoma Management in North Carolina 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Live Webinar
October 23 • 12:00 – 1:00

Lymphoma Management in North Carolina
Anne W. Beaven, MD
 

 

Feature image for Head and Neck Cancer Management in North Carolina 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Live Webinar
December 18 • 12:00 – 1:00

Head and Neck Cancer Management in North Carolina
Sumita Trivedi, MD
 

 

Live Webinar Zoom Instructions.

 

Site Attendee Instructions. 


Self-Paced Courses, Online Courses

Feature image for H. Pylori Testing and Treatment for Gastric Cancer Prevention 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Available
March 4, 2024 – March 3, 2026

H. Pylori Testing and Treatment for Gastric Cancer Prevention
Meira Epplein, PhD
Katherine Garman, MD

Katherine Garman, MD, and Meira Epplein, PhD, will provide information on gastric cancer and important risk factors such as H. pylori infection. We will describe some of the racial disparities associated with gastric cancer in the US, highlighting those that are relevant for North Carolina. We will also discuss H. pylori as a modifiable risk factor and we will review current guidelines on H. pylori testing, treatment, eradication testing, and the growing problem of antibiotic resistance.

 

Feature image for Caring for Older Adults with Acute Leukemia in North Carolina: Updates for 2023 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Available
March 4, 2024 – March 3, 2026

Caring for Older Adults with Acute Leukemia in North Carolina
Daniel Richardson, MD, MA, MSc

Daniel Richardson, MD, MA, MSc, will explore best practices to approach the care of older adults with leukemia. He will also discuss novel therapeutic options for patients with acute lymphoblastic and acute myeloid leukemia alongside practical considerations to approach shared decision-making.

 

Feature image for Update on Prostate Cancer Screening 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Available
February 1, 2024 – January 31, 2026

Update on Prostate Cancer Screening
Marc Bjurlin, DO, MSc, FACOS

Marc Bjurlin, DO, MSc, FACOS, will give a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.

 

Feature image for Genitourinary Cancer Management in North Carolina: Updates for 2023 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Available
February 1, 2024 – January 31, 2026

Genitourinary Cancer Management in North Carolina: Updates for 2023
Hung-Jui (Ray) Tan, MD, MSHPM

Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.

 

Feature image for Sarcoma Management in North Carolina: Updates for 2023 
Research to Practice
CME • NCPD/CNE • ACPE • ASRT • CTR
 
Available
November 1, 2023 – October 31, 2025

Sarcoma Management in North Carolina: Updates for 2023
Mark Woodcock, MD

A broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.

 

Feature image for Lymphoma Management in North Carolina: Updates for 2023 
Research to Practice
 NCPD/CNE • ACPE • ASRT • CTR
 
Available
October 2, 2023 – October 1, 2025

Lymphoma Management in North Carolina: Updates for 2023
Natalie Grover, MD

Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.

 

Feature image for Radiation Oncology Management of Lung Cancer in NC: Update on Small-Cell Lung Cancer 
Research to Practice
NCPD/CNE • ACPE • ASRT • CTR
 
Available
September 8, 2023 – September 7, 2025
 

Radiation Oncology Management of Lung Cancer in NC: Update on Small-Cell Lung Cancer
Ashley Weiner, MD, PhD

Ashley Weiner, MD, PhD, will focus on the role of radiotherapy for small-cell lung cancer. She will begin with an overview of radiation oncology, then walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she will review the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).

 

Feature image for The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond... 
Research to Practice
NCPD/CNE • ACPE • ASRT • CTR
 
Available
July 3, 2023 – July 2, 2025
 

The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond...
Jethro L. Hu, MD

Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.

 

Feature image for Multidisciplinary/Multimodality Management of Locally Recurrent Rectal Cancer 
Research to Practice
ACPE • ASRT • CTR
 
Available
June 29, 2023 – June 27, 2024

Multidisciplinary/Multimodality Management of Locally Recurrent Rectal Cancer
José Gaston Guillem, MD, MPH, MBA

Despite advancements in multimodality therapy and optimal surgery for rectal cancer, approximately 10% of patients will experience a local failure. Expert management of a local recurrence is extremely important, as it directly impacts the quality of life and survival. Approximately 50% of patients who recur are resectable. Those that undergo a complete resection do better than those who are not able to undergo a complete resection. Jose Gaston Guillem, MD, MPH, MBA, will describe how at UNC Medical Center a team of experts carefully reviews each individual patient during a Weekly GI Tumor Board and collaboratively develop a treatment plan which defines the specific timing and sequence of care for each patient. The Colorectal Surgeons at UNC work closely with other members of the UNC Lineberger GI Oncology Program to ensure that patients receive the most advanced multispecialty care in a timely fashion.

 

Feature image for Clinical Updates in Breast Oncology 
Research to Practice
NCPD/CNE – ACPE – ASRT – CTR
 
Available
May 2, 2023 - May 1, 2025
 Innovations in breast oncology can translate to improved patient outcomes for patients with early and late-stage disease. In this webinar, Dr. Ray will discuss the latest research findings and how they can be translated into the clinical care of patients with breast cancer.

 

Acute Myeloid Leukemia with AML-MRC 
Research to Practice
NCPD/CNE – ACPE – CTR
 
Available
February 3, 2023 – February 2, 2025
 Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.

 

Cardiotoxicity of Targeted Cancer Therapies 
Research to Practice
NCPD/CNE – ACPE  – CTR
 
Available
February 3, 2023 – February 2, 2025
 Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.

 

Demystifying Molecular-Based Tests in Head and Neck Cancers 
Research to Practice
NCPD/CNE – ACPE – CTR
 
Available
January 30, 2023 – January 29, 2025
 Siddharth Sheth, DO, MPH, will provide a brief overview of clinical factors relevant to head and neck cancers and basic management. The main focus will be the current use of technologies that aid with the diagnosis, treatment selection, and monitoring of patients with head and neck cancers. This includes next-generation sequencing assays for DNA sequencing, RNA sequencing, and circulating tumor DNA. The goal of the presentation is for providers to be comfortable with ordering and basic interpretation of these tests.